By Will Ferguson, College of Arts & Sciences PULLMAN, Wash. – Technology being developed at Washington State University provides a non-invasive approach for diagnosing prostate cancer and tracking the disease’s progression.
By Eric Sorensen, WSU science writer SPOKANE, Wash. – A Washington State University researcher has found a way that prostate cancer cells hijack the body’s bone maintenance, facilitating the spread of bone cancers present in some 90 percent of prostate-cancer fatalities.
By Lorraine Nelson, WSU Spokane SPOKANE, Wash. – A genetic testing company will make available tests for prostate cancer survival and breast cancer recurrence to patients following identification of the biomarker genes in a Washington State University laboratory.
SEATTLE – An imaging agent discovered by a Washington State University researcher that homes in on prostate cancer will be developed for human clinical trials thanks to a two-year $2 million federal Small Business Innovation Research grant.
By Eric Sorensen, WSU science writer SPOKANE, Wash. – Washington State University researchers have found a mechanism by which omega-3 fatty acids inhibit the growth and spread of prostate cancer cells. The findings, which are at odds with a 2013 study asserting that omega-3s increase the risk of prostate cancer, point the way to more […]
PULLMAN, Wash. – The genes involved in the progression of prostate cancer from non-threatening to highly malignant are the focus of a new research project at Washington State University. Grant D. Trobridge has received an award of $417,818 from the National Cancer Institute to identify which gene mutations cause the cancer to become threatening. Prostate […]